Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Assets (2016 - 2025)

Historic Assets for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $4.1 billion.

  • Icu Medical's Assets fell 469.55% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year decrease of 469.55%. This contributed to the annual value of $4.2 billion for FY2024, which is 398.56% down from last year.
  • Per Icu Medical's latest filing, its Assets stood at $4.1 billion for Q3 2025, which was down 469.55% from $4.1 billion recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Assets peaked at $4.7 billion during Q1 2022, and registered a low of $1.8 billion during Q1 2021.
  • Moreover, its 5-year median value for Assets was $4.3 billion (2024), whereas its average is $3.8 billion.
  • As far as peak fluctuations go, Icu Medical's Assets soared by 16890.16% in 2022, and later tumbled by 581.66% in 2023.
  • Icu Medical's Assets (Quarter) stood at $1.9 billion in 2021, then skyrocketed by 140.1% to $4.5 billion in 2022, then dropped by 3.04% to $4.4 billion in 2023, then decreased by 3.99% to $4.2 billion in 2024, then dropped by 2.4% to $4.1 billion in 2025.
  • Its Assets was $4.1 billion in Q3 2025, compared to $4.1 billion in Q2 2025 and $4.2 billion in Q1 2025.